1. Home
  2. STRA vs PVLA Comparison

STRA vs PVLA Comparison

Compare STRA & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.63

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$111.98

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
PVLA
Founded
2017
2015
Country
United States
United States
Employees
N/A
14
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
STRA
PVLA
Price
$80.63
$111.98
Analyst Decision
Buy
Strong Buy
Analyst Count
2
16
Target Price
$96.50
$161.13
AVG Volume (30 Days)
318.0K
336.8K
Earning Date
04-23-2026
04-06-2026
Dividend Yield
2.96%
N/A
EPS Growth
15.85
N/A
EPS
5.41
N/A
Revenue
$997,137,000.00
N/A
Revenue This Year
$3.93
N/A
Revenue Next Year
$4.93
N/A
P/E Ratio
$14.95
N/A
Revenue Growth
57.23
N/A
52 Week Low
$72.17
$18.23
52 Week High
$92.98
$151.18

Technical Indicators

Market Signals
Indicator
STRA
PVLA
Relative Strength Index (RSI) 49.83 45.77
Support Level $78.87 $85.53
Resistance Level $82.77 $147.47
Average True Range (ATR) 2.69 8.32
MACD 0.01 -3.97
Stochastic Oscillator 34.92 6.36

Price Performance

Historical Comparison
STRA
PVLA

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: